As artificial intelligence (AI) and algorithm-driven technologies become increasingly embedded in healthcare, defense attorneys are encountering new challenges in the realm of product liability. Plaintiffs are beginning to assert that failures or errors in AI-powered diagnostic tools, clinical support systems, or digital health apps constitute product defects, drawing on traditional strict liability principles. In these claims, software, and algorithms—once seen merely as intangible logic or services—are argued to be “products” subject to liability, especially when an adverse outcome occurs in a medical setting.
This legal development poses complex questions. First, attorneys must address whether intangible code or algorithms can be classified as a “product” under current product liability law. While courts have begun entertaining this theory, they have not ruled or remain hesitant to treat software as a traditional product. As a result, one of the chief defense strategies should focus on arguing that most medical software, especially when delivered as a service or a tool (rather than a stand-alone device), remains outside the statutory definition of a “product.” Established case law often distinguishes between tangible products and services or intellectual property, and this distinction can be essential in seeking dismissal of claims at an early stage.
Another critical area of defense is the defendant’s adherence to regulatory standards. If the AI tool or software in question has received clearance from agencies like the FDA, defense counsel can invoke regulatory preemption. This means that if a defendant can show robust compliance with existing safety and validation requirements, it becomes much harder for a plaintiff to prove the existence of an actionable defect. Moreover, regular audit trails of updates, risk documentation, and alignment with evolving legal guidance can further insulate a manufacturer or provider from liability.
Additionally, it is often pivotal to emphasize the continued role of human medical judgment. Most AI-based medical tools are designed to assist, not replace, trained health professionals. When adverse events occur, defense attorneys should explore and highlight whether clinicians deviated from standard protocols, ignored AI-generated warnings, or misused the system in ways contrary to its intended use. Such facts help to break the chain of causations, reminding courts and juries that these technologies are tools rather than infallible or autonomous actors.
Causation itself is another area where defense teams must vigorously contest plaintiffs’ claims. Medical outcomes are influenced by a multitude of factor-patient characteristics, physician decisions, and environmental variables. Demonstrating the difficulty of pinpointing a single causative “defect” within a complex software system, especially one that processes vast and variable data sets, can undercut the basis for liability. Bringing technical and clinical experts into the process early helps to clarify these complexities and educate both judges and jury.
It is also important for the defense to consider the evolutionary nature of AI systems. Unlike traditional products, AI models may change and improve after deployment as they are retrained on new data sets. Defense counsel should argue that liability for “post-launch” behavior should not mirror liability for static devices, especially if updates or retraining are managed by parties outside the original developer’s control.
In practical terms, successful defense in these cases relies on a multifaceted strategy: arguing the fundamental legal definition of “product,” meticulously documenting regulatory compliance, scrutinizing the chain of clinical decision-making, and enlisting expert testimony to challenge causation and technical allegations. Visual aids, timelines, and clear explainers about the interplay between algorithmic recommendations and human interventions are invaluable for making complex subjects more accessible in the courtroom.
To summarize, defending against product liability claims in medical AI cases demands both traditional legal analysis and sophisticated engagement with rapidly evolving technology. Defense attorneys should be proactive—auditing compliance, documenting product development and warnings, and preparing to demonstrate both the responsible use of AI and the crucial role of human judgment in patient care. By staying ahead of legal and technological trends, defense counsel can more effectively shield clients from the expanding risks posed by allegations of AI “product defects” in medicine.
If you need Legal Nurse Consulting expertise, contact R&G Medical Legal Solutions.